Ketryx, a provider of an agentic continuous compliance platform for safety-critical product development, announced today that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. Hawkins also participated in the company’s Series B financing, underscoring his commitment to advancing AI-driven solutions in regulated sectors.
The appointment highlights Ketryx’s focus on addressing the bottleneck that artificial intelligence presents in life sciences and other safety-critical industries. The company’s platform helps organizations such as medical device manufacturers, pharmaceutical companies, and robotics developers accelerate product development by automating the generation of compliant documentation, maintaining continuous traceability, and enabling safe and verifiable AI at scale within the tools teams already use.
“I’ve spent my career working in highly regulated industries where compliance is critical but can slow down innovation,” said Hawkins. “Ketryx has built a platform that removes that tension, allowing teams to move faster without compromising quality or safety. I’m excited to help guide the company as it scales.”
Ketryx’s platform is trusted by four of the world’s top five medical device manufacturers. According to the company, its AI agents reduce manual work by up to 90 percent and help teams identify and close compliance gaps, improving both speed and quality across the product lifecycle. By overlaying existing tools, the platform automates documentation and creates traceability without disrupting established workflows.
“Bill’s leadership at Medtronic and his deep understanding of the challenges in bringing safe, innovative products to market make him an invaluable addition to our board,” said Stefan K. Bucher, CEO of Ketryx. “His insights will be instrumental as we continue to expand our platform and help more companies in safety-critical industries harness the power of AI.”
The life sciences industry faces increasing pressure to adopt AI while navigating stringent regulatory requirements. Ketryx positions itself as a solution that allows companies to integrate AI into their development processes without sacrificing compliance. The company’s recent financing and board appointment signal growing investor and industry confidence in its approach.
For more information about Ketryx and its platform, visit www.ketryx.com.
